Projected benefits from integrating NTD programs sub-Sahara

Wuchereria bancrofti vespid, Immune response, Serum immune complexes diagnosis, Diethylcarbamazine (DEC), Wolbachia in filarial parasites, Interdigital skin lesions, Urban Filariasis, Doxycycline, mass drug administration program, Filarial Lymphedema Care, Detection of filarial parasites, Albendazole, research abstracts

Moderators: jenjay, Cassie, patoco, Birdwatcher, Senior Moderators

Projected benefits from integrating NTD programs sub-Sahara

Postby patoco » Fri Jul 07, 2006 8:23 am

Projected benefits from integrating NTD programs in sub-Saharan Africa.

July 2006

Brady MA, Hooper PJ, Ottesen EA.

Lymphatic Filariasis Support Center, The Task Force for Child Survival and Development, 750 Commerce Drive, Suite 400, Decatur, Georgia 30030, USA.

The integration of preventive chemotherapy programs (PCPs) targeting multiple neglected tropical diseases (NTDs) with similar strategic approaches offers opportunities for enhanced cost-effectiveness. To estimate the potential cost savings and health outcomes of integrated programs, the data available for five NTDs (lymphatic filariasis, onchocerciasis, intestinal helminthiasis, schistosomiasis and trachoma) can be used to define eligible target populations, the probable overlap of at-risk populations, and the cost per person treated in stand-alone and integrated programs. If all targets for 2006 in sub-Saharan Africa are met, then savings of 26-47% can be projected from such integration (a cost of US $58-81 million versus $110 million for stand-alone PCPs). These first estimates can be refined as empirical data become available from integrated PCPs in the future.

http://www.ncbi.nlm.nih.gov/entrez/quer ... med_docsum

.................

Lymphedema People

http://www.lymphedemapeople.com
patoco
Site Admin
 
Posts: 2175
Joined: Thu Jun 08, 2006 9:07 pm

Return to Lymphatic Filariasis

Who is online

Users browsing this forum: No registered users and 2 guests


cron